Abstract:
In some embodiments, the present disclosure pertains to methods of removing heteroatoms from a fluid by associating the fluid with one or more adsorbents, where the association results in the removal of the heteroatoms from the fluid. The association may occur by associating the fluid with a single adsorbent or a plurality of adsorbents in a sequential manner that maximizes heteroatom removal efficacy. The methods may be utilized to remove heteroatom-containing compounds from various fluids, such as fuels, hydrocarbons, alcohols, water, organic solvents, and combinations thereof. The one or more adsorbents may include, without limitation, activated carbon, zeolites, ion exchanged zeolites, ion impregnated zeolites, alumina, alumina nanowires, carbon-based supports, and combinations thereof. The methods of the present disclosure can be utilized to reduce heteroatoms in the fluid by more than about 50%, by more than about 80%, or by more than about 99%.
Abstract:
A hydrogen gas recovery system according to the present ingestion is configured by a condensation and separation apparatus (A) that condenses and separates chlorosilanes from a hydrogen-containing reaction exhaust gas exhausted from a polycrystalline silicon production step, a compression apparatus (B) that compresses the hydrogen-containing reaction exhaust gas, an absorption apparatus (C) that absorbs and separates hydrogen chloride by contacting the hydrogen-containing reaction exhaust gas with an absorption liquid, a first adsorption apparatus (D) comprising an adsorption column filled with activated carbon for adsorbing and removing methane, hydrogen chloride, and part of the chlorosilanes each contained in the hydrogen-containing reaction exhaust gas, a second adsorption apparatus (E) comprising an adsorption column filled with synthetic zeolite that adsorbs and removes methane contained in the hydrogen-containing reaction exhaust gas, and a gas line (F) that recovers a purified hydrogen gas having a reduced concentration of methane.
Abstract:
A system and process for the recovery of at least one halogenated hydrocarbon from a gas stream. The recovery includes adsorption by exposing the gas stream to an adsorbent with a lattice structure having pore diameters with an average pore opening of between about 5 and about 50 angstroms. The adsorbent is then regenerated by exposing the adsorbent to a purge gas under conditions which efficiently desorb the at least one adsorbed halogenated hydrocarbon from the adsorbent. The at least one halogenated hydrocarbon (and impurities or reaction products) can be condensed from the purge gas and subjected to fractional distillation to provide a recovered halogenated hydrocarbon.
Abstract:
The removal of fluoroalkanes from fluoroalkane-containing hydrocarbon streams, preferably C3 to C5 hydrocarbon streams. The fluoroalkane-containing hydrocarbon stream is contacted with an adsorbent containing a strong acid function, preferably a silica gel or a strong cation ion-exchange resin having sulfonic acid functionality
Abstract:
The inventive technology may involve, in particular embodiments, novel use of a non-porous, high surface energy stationary phase to adsorb, in reversible fashion, the most polar component of a resins fraction of an input hydrocarbon when a mobile phase is passed over the stationary phase. Such reversible adsorption prevents irreversibly adsorption of such components on active stationary phase(s) downflow of the non-porous, high surface energy stationary phase, thereby conserving stationary phase costs and increasing resolution of resins elutions, and accuracy of hydrocarbon component results. Aspects of the inventive technology may also involve a novel combination of a solubility based asphaltene component fractionating and analysis method and an adsorption chromatography method for separating and/or analyzing saturate, aromatics and resins components of an input hydrocarbon.
Abstract:
Devices, systems, and methods reduce levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood by selective adsorption. The devices, systems, and methods are useful in situations where abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators occur, or during events that do induce or have the potential for inducing abnormal production of pro-inflammatory or anti-inflammatory stimulators or mediators. The devices, systems, and methods serve to prevent, control, reduce, or alleviate the severity of the inflammatory response and disease states that are associated with abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators.
Abstract:
Devices, systems, and methods reduce levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood by selective adsorption. The devices, systems, and methods are useful in situations where abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators occur, or during events that do induce or have the potential for inducing abnormal production of pro-inflammatory or anti-inflammatory stimulators or mediators. The devices, systems, and methods serve to prevent, control, reduce, or alleviate the severity of the inflammatory response and disease states that are associated with abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators.
Abstract:
Methods, apparatuses, and kits for fractionating complex mixtures of biological molecules are provided. In one aspect the methods provided include providing a series of different sorbents, introducing the complex mixture to the series of sorbents, contacting serially the complex mixture with each of the sorbents, and capturing biomolecular components from the complex mixture on the sorbents so that each of the sorbents captures a substantially unique subset of said plurality of biomolecular components.
Abstract:
Disclosed are a gas purification-treating agent and a gas purifying apparatus, which treat carbon monoxide and/or hydrogen contained in a gas in the presence of oxygen. The gas purification-treating agent consists of an adsorbent having carbon dioxide and/or water adsorptivity, and a metal or metal compound which is carried on the adsorbent and activates oxidation reaction of carbon monoxide and/or hydrogen. The gas purifying apparatus has the gas purification-treating agent contained in a container having a gas inlet and a gas outlet. The adsorbent adsorbs carbon dioxide and/or water contained originally in the gas, as well as, carbon dioxide and/or water to be formed by the oxidation reaction of carbon monoxide and/or hydrogen. The metal or metal compound is at least one selected from Au-on-metal oxides, Au-on-metal hydroxides and an Au colloidal powder, or palladium and/or platinum.
Abstract:
Disclosed are a gas purification-treating agent and a gas purifying apparatus, which treat carbon monoxide and/or hydrogen contained in a gas in the presence of oxygen. The gas purification-treating agent consists of an adsorbent having carbon dioxide and/or water adsorptivity, and a metal or metal compound which is carried on the adsorbent and activates oxidation reaction of carbon monoxide and/or hydrogen. The gas purifying apparatus has the gas purification-treating agent contained in a container having a gas inlet and a gas outlet. The adsorbent adsorbs carbon dioxide and/or water contained originally in the gas, as well as, carbon dioxide and/or water to be formed by the oxidation reaction of carbon monoxide and/or hydrogen. The metal or metal compound is at least one selected from Au-on-metal oxides, Au-on-metal hydroxides and an Au colloidal powder, or palladium and/or platinum.